Literature DB >> 33716768

Tissue-Engineered Skeletal Muscle Models to Study Muscle Function, Plasticity, and Disease.

Alastair Khodabukus1.   

Abstract

Skeletal muscle possesses remarkable plasticity that permits functional adaptations to a wide range of signals such as motor input, exercise, and disease. Small animal models have been pivotal in elucidating the molecular mechanisms regulating skeletal muscle adaptation and plasticity. However, these small animal models fail to accurately model human muscle disease resulting in poor clinical success of therapies. Here, we review the potential of in vitro three-dimensional tissue-engineered skeletal muscle models to study muscle function, plasticity, and disease. First, we discuss the generation and function of in vitro skeletal muscle models. We then discuss the genetic, neural, and hormonal factors regulating skeletal muscle fiber-type in vivo and the ability of current in vitro models to study muscle fiber-type regulation. We also evaluate the potential of these systems to be utilized in a patient-specific manner to accurately model and gain novel insights into diseases such as Duchenne muscular dystrophy (DMD) and volumetric muscle loss. We conclude with a discussion on future developments required for tissue-engineered skeletal muscle models to become more mature, biomimetic, and widely utilized for studying muscle physiology, disease, and clinical use.
Copyright © 2021 Khodabukus.

Entities:  

Keywords:  Duchenne Muscle dystrophy; disease modeling; fiber-type; innervation; myosin heavy chain; satellite cell; skeletal muscle; tissue engineering

Year:  2021        PMID: 33716768      PMCID: PMC7952620          DOI: 10.3389/fphys.2021.619710

Source DB:  PubMed          Journal:  Front Physiol        ISSN: 1664-042X            Impact factor:   4.566


  318 in total

1.  Excitability and isometric contractile properties of mammalian skeletal muscle constructs engineered in vitro.

Authors:  R G Dennis; P E Kosnik
Journal:  In Vitro Cell Dev Biol Anim       Date:  2000-05       Impact factor: 2.416

2.  A simplified method for tissue engineering skeletal muscle organoids in vitro.

Authors:  J Shansky; M Del Tatto; J Chromiak; H Vandenburgh
Journal:  In Vitro Cell Dev Biol Anim       Date:  1997-10       Impact factor: 2.416

3.  Skeletal muscle atrophy in bioengineered skeletal muscle: a new model system.

Authors:  Peter H U Lee; Herman H Vandenburgh
Journal:  Tissue Eng Part A       Date:  2013-06-26       Impact factor: 3.845

4.  ERBB3 and NGFR mark a distinct skeletal muscle progenitor cell in human development and hPSCs.

Authors:  Michael R Hicks; Julia Hiserodt; Katrina Paras; Wakana Fujiwara; Ascia Eskin; Majib Jan; Haibin Xi; Courtney S Young; Denis Evseenko; Stanley F Nelson; Melissa J Spencer; Ben Van Handel; April D Pyle
Journal:  Nat Cell Biol       Date:  2017-12-18       Impact factor: 28.824

5.  Calcium-activated force of human muscle fibers following a standardized eccentric contraction.

Authors:  Seung Jun Choi; Jeffrey J Widrick
Journal:  Am J Physiol Cell Physiol       Date:  2010-09-01       Impact factor: 4.249

Review 6.  Engineered skeletal muscles for disease modeling and drug discovery.

Authors:  Jason Wang; Alastair Khodabukus; Lingjun Rao; Keith Vandusen; Nadia Abutaleb; Nenad Bursac
Journal:  Biomaterials       Date:  2019-08-08       Impact factor: 12.479

7.  Skeletal and cardiac myopathies in mice lacking utrophin and dystrophin: a model for Duchenne muscular dystrophy.

Authors:  R M Grady; H Teng; M C Nichol; J C Cunningham; R S Wilkinson; J R Sanes
Journal:  Cell       Date:  1997-08-22       Impact factor: 41.582

8.  Slow-to-fast transformation of denervated soleus muscles by chronic high-frequency stimulation in the rat.

Authors:  L Gorza; K Gundersen; T Lømo; S Schiaffino; R H Westgaard
Journal:  J Physiol       Date:  1988-08       Impact factor: 5.182

9.  Bioengineered human myobundles mimic clinical responses of skeletal muscle to drugs.

Authors:  Lauran Madden; Mark Juhas; William E Kraus; George A Truskey; Nenad Bursac
Journal:  Elife       Date:  2015-01-09       Impact factor: 8.140

10.  Low glucose but not galactose enhances oxidative mitochondrial metabolism in C2C12 myoblasts and myotubes.

Authors:  Moustafa Elkalaf; Michal Anděl; Jan Trnka
Journal:  PLoS One       Date:  2013-08-05       Impact factor: 3.240

View more
  6 in total

1.  Enhancing Myoblast Fusion and Myotube Diameter in Human 3D Skeletal Muscle Constructs by Electromagnetic Stimulation.

Authors:  Lisanne Terrie; Margherita Burattini; Sandra Van Vlierberghe; Lorenzo Fassina; Lieven Thorrez
Journal:  Front Bioeng Biotechnol       Date:  2022-06-22

Review 2.  Contractile force assessment methods for in vitro skeletal muscle tissues.

Authors:  Camila Vesga-Castro; Javier Aldazabal; Ainara Vallejo-Illarramendi; Jacobo Paredes
Journal:  Elife       Date:  2022-05-23       Impact factor: 8.713

Review 3.  Neuromuscular Development and Disease: Learning From in vitro and in vivo Models.

Authors:  Zachary Fralish; Ethan M Lotz; Taylor Chavez; Alastair Khodabukus; Nenad Bursac
Journal:  Front Cell Dev Biol       Date:  2021-10-27

4.  R-spondin3 is a myokine that differentiates myoblasts to type I fibres.

Authors:  Yoshitaka Mita; Haonan Zhu; Yasuro Furuichi; Hiroki Hamaguchi; Yasuko Manabe; Nobuharu L Fujii
Journal:  Sci Rep       Date:  2022-07-29       Impact factor: 4.996

5.  Differential microRNA profiles of intramuscular and secreted extracellular vesicles in human tissue-engineered muscle.

Authors:  Christopher G Vann; Xin Zhang; Alastair Khodabukus; Melissa C Orenduff; Yu-Hsiu Chen; David L Corcoran; George A Truskey; Nenad Bursac; Virginia B Kraus
Journal:  Front Physiol       Date:  2022-08-25       Impact factor: 4.755

6.  nNOS-derived NO modulates force production and iNO-derived NO the excitability in C2C12-derived 3D tissue engineering skeletal muscle via different NO signaling pathways.

Authors:  Matias Mosqueira; Lisa-Mareike Scheid; Dominik Kiemel; Talisa Richardt; Mona Rheinberger; Dirk Ollech; Almut Lutge; Tim Heißenberg; Lena Pfitzer; Lisa Engelskircher; Umut Yildiz; Isabel Porth
Journal:  Front Physiol       Date:  2022-08-15       Impact factor: 4.755

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.